Vangl2em1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.205
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Fasted Clinical Chemistry / Glycerol
|
HET
|
f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.786
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Fasted Clinical Chemistry / Glycerol
|
HET
|
8f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.866
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Fasted Clinical Chemistry / LDL-cholesterol
|
HET
|
f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.743
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Fasted Clinical Chemistry / LDL-cholesterol
|
HET
|
f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.885
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HET
|
f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HET
|
8f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.00706
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Simplified IPGTT / Blood glucose concentration
|
HET
|
35f:40m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Fasted Clinical Chemistry / Free fatty acids
|
HET
|
f:2m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Fasted Clinical Chemistry / Free fatty acids
|
HET
|
8f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.737
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Fasted Clinical Chemistry / Total cholesterol
|
HET
|
f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Fasted Clinical Chemistry / Total cholesterol
|
HET
|
8f:9m
|
Linear Mixed Model framework, LME, including Weight
|
2.85×10-05
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Fasted Clinical Chemistry / Glucose
|
HET
|
8f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
9.36×10-05
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Fasted Clinical Chemistry / Glucose
|
HET
|
f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.129
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Creatinine
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.609
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
2f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
3f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
f:1m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
1f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00460
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0345
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.141
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.408
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
f:1m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
3f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
2f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
1f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.000160
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0652
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.358
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00647
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0259
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
1f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.558
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
2f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
f:1m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.155
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.468
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
1f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.975
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
f:1m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
2f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
1f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00848
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.269
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.915
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Total cholesterol
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0974
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Total protein
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.346
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Cholesterol ratio
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.946
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.945
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Albumin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.362
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
6f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.392
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
6f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.618
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Total bilirubin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.625
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.532
|
Successful |
Vangl2Lp
|
MRC Harwell
|
DEXA / Fat/Body weight
|
HET
|
8f:16m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00254
|
Successful |
Vangl2Lp
|
MRC Harwell
|
DEXA / Fat mass
|
HET
|
8f:16m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0266
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
2f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
3f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
1f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00180
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0354
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0704
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Calorimetry / Carbon dioxide production
|
HET
|
675f:1643m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HET
|
2f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HET
|
3f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.132
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HET
|
f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.147
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HET
|
1f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.431
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Calorimetry / Oxygen consumption
|
HET
|
675f:1643m
|
|
|
NotProcessed |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Calcium
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.964
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Glucose
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.552
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Dysmorphology / fat distribution
|
HET
|
8f:19m
|
|
|
NotProcessed |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
6f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.532
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.175
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Phosphorus
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
7.68×10-06
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
2f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
f:1m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
1f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.182
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.801
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.885
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
2f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
3f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
f:1m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0157
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
1f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.135
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.427
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.270
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
3f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
2f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
1f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.278
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.473
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.982
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
f:1m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
3f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
2f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0145
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
1f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0205
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.896
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Insulin Blood Level / Insulin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.885
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
30f:40m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
3f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
2f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
f:1m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
1f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0436
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.365
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.424
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
3f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
f:1m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
2f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
1f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0762
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.139
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.520
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
2f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
f:1m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
3f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0959
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.376
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
1f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.491
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
f:1m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
2f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
3f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.181
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
1f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.202
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.700
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
3f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
f:1m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
2f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
1f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0600
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.475
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.882
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
2f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
3f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
f:1m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0485
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
1f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.305
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
1f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.619
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
2f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
1f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
3f:m
|
|
|
NotProcessed |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0752
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
1f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.402
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
1f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.573
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Gross Morphology Embryo E14.5-E15.5 / Edema
|
HET
|
8f:14m
|
Supplied as data
|
1.00
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Gross Morphology Embryo E14.5-E15.5 / Edema
|
HOM
|
5f:6m
|
Supplied as data
|
1.00
|
Successful |
Vangl2Lp
|
MRC Harwell
|
Simplified IPGTT / Glucose response AUC
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.768
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Triglycerides
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0182
|
Successful |
Vangl2em1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.140
|
Successful |